Clinical Trial Update: A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes Mellitus [NA]

View source ↗

Summary

Completed clinical trial evaluating an implantable continuous glucose monitoring sensor to improve glycemic control in diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2021-09-10